xxiicentury.com - מכפיל מחיר להכנסות עתידי XXII

22nd Century Group (XXII) is implementing sustainable farming principles to protect soils from toxins. Global logistics and trade tariffs significantly impact the margins of this biotech business. The financial crisis stripped the company of its pricing power, forcing it to dump inventories. The forward P/S trend reflects market expectations, where the current parameter equals 0.00.
xxiicentury.com - פילוחים אנליטיים ומדדי מפתח (XXII)

22nd Century Group (XXII) investments in plant genetics to create nicotine-free tobacco position the company as a high-tech asset with a long-term payback horizon. By analyzing the forward price-to-sales valuation, an investor compares the current market value of the business with expected sales volume, which allows for an assessment of how quickly quotes adapt to fundamental news and helps determine a fair multiplier for this speculative class of securities.